IFN-γ switches M2-polarised tumour-associated macrophages (TAMs), the main sources of VEGF in the tumour microenvironment (TME), to an M1 phenotype, reducing VEGF production [30,31]. The gene discussed is IFNG; the disease is neoplasm.